Testing a new drug for cryptosporidium infection in healthy adults
Part of Digestive system, Infections clinical trials.
This trial tests a new drug, EDI048, to see how well it works and how safe it is for treating cryptosporidium infection. It is for healthy volunteers who will be intentionally exposed to the infection under controlled conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 50 years old and in good health.
- Have a body mass index (BMI) between 18 and 32.
- Understand the risks of cryptosporidium infection and how to prevent spreading it to others.
- Not work in healthcare, daycare, or as a food handler.
- Not live with a pregnant woman, a child under 4, an elderly person over 65, or someone with a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children aged 6 months to 5 years with diarrhea caused by Cryptosporidium. It aims to understand how the infection develops over time and how it affects children.
This trial tests an investigational medicine called CDI-988 to see if it can prevent or treat norovirus infection. Healthy adults will be intentionally exposed to a mild norovirus strain to see how the medicine works.
This trial tests a new medicine made from a weakened yeast that is designed to fight a bacteria called C. diff, which can cause severe diarrhea. It's a first-in-human safety study, so the main goal is to see if the medicine is safe and how your body handles it.
This study tests an experimental antibiotic called BWC0977 to see if it is safe and well-tolerated when given as single and multiple doses. It is for healthy volunteers to understand how the drug behaves in the body before moving to patient trials.
This study gives healthy volunteers a specially prepared dose of Clostridioides difficile (C. diff), a bacteria that can cause diarrhea and gut problems, to learn how the infection develops. By participating, you may help researchers better understand and prevent C. diff infections in the future.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
Hear when a new Cryptosporidiosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.